Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement GH11-002, Initial Review, 24030-24031 [2011-10385]

Download as PDF 24030 Federal Register / Vol. 76, No. 83 / Friday, April 29, 2011 / Notices practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project National Survey of Primary Care Policies for Managing Patients with High Blood Pressure, High Cholesterol, or Diabetes—New—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description Cardiovascular disease is a leading cause of death for men and women in the United States, among the most costly health problems facing our nation today, and among the most preventable. Heart disease and stroke also contribute significantly to disability, with nearly three million American people reporting disability from these causes. Additionally, over 50% of diabetics have high blood pressure, high cholesterol, or both conditions. To reduce the burden of cardiovascular disease, the federal Centers for Disease Control and Prevention (CDC) works with a broad array of public- and private-sector stakeholders, including years after completion of the baseline survey. Information from both cycles of data collection will be compared to monitor changes in health systems uptake and dissemination of health systems technology. The survey will be pretested with approximately 16 respondents before dissemination. The target population for the NSPCP is practice managers of non-federally run primary care physician practices that include at least one Family Practitioner or at least one physician specializing in internal medicine. Respondents will be drawn from a nationally representative sample of physician practices. OMB approval is requested for three years. Approximately 900 physicians will participate in the first cycle of webbased data collection, and 900 physicians will participate in the twoyear follow-up survey. An average of 600 respondents per year will participate in the NSPCP. Results will be used by CDC to improve services to partners through development of translation pieces or technical assistance aids that address gaps in the use of evidence-based interventions. Most importantly, the study will provide primary care practices with information that can be used to inform their systems for managing patients with chronic conditions and to improve the quality of care delivered. Participation is voluntary, and all responses will be de-identified. There are no costs to respondents other than their time. state and local health departments, community-based organizations, professional organizations, and health care practitioners. In 2005, CDC’s Division for Heart Disease and Stroke Prevention (DHDSP) began developing evaluation indicators that reflect evidence-based outcomes from policy, systems, and environmental changes for heart disease and stroke prevention. These indicators are needed to provide common measures that CDC, CDC-funded state Heart Disease and Stroke Prevention programs, and other partners can use to show progress toward achieving outcomes in heart disease and stroke prevention and control efforts. Many of the indicators that reflect outcomes of short-term policy and systems changes do not have readily available data sources. This is particularly true for outcomes related to health care systems changes. In 2011, CDC proposes to conduct the first cycle of data collection for the National Survey of Primary Care Policies for Managing Patients with High Blood Pressure, High Cholesterol, or Diabetes (NSPCP). The web-based survey will collect information on physician practices’ use of evidencebased systems, including multidisciplinary team approaches for chronic disease treatment, electronic health records (EHR) with features appropriate for treating patients with chronic disease (e.g., clinical decision supports, patient registries), and patient follow-up mechanisms. A follow-up questionnaire will be distributed two ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Number of respondents Avg. burden per response (in hr) Total burden (in hr) Type of respondents Form name Physician ....................................................... Medical Secretary ......................................... Physician ....................................................... Cognitive Testing Protocol ... NSPCP Screener .................. NSPCP ................................. 5 1,333 600 1 1 1 75/60 5/60 20/60 6 111 200 Total ....................................................... ............................................... ........................ ........................ ........................ 317 Dated: April 25, 2011. Carol Walker, Acting Reports Clearance Officer, Centers for Disease Control and Prevention [FR Doc. 2011–10384 Filed 4–28–11; 8:45 am] srobinson on DSKHWCL6B1PROD with NOTICES BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement GH11–002, Initial Review Correction: This notice was published in the Federal Register on April 12, 2011, Volume 76, Number 70, Page VerDate Mar<15>2010 17:39 Apr 28, 2011 Jkt 223001 PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 20355. The contact person for the aforementioned meeting has been changed to the following: Contact Person for More Information: Diana Bartlett, M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop D–72, Atlanta, Georgia 30333, Telephone: (404) 639–4938. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the E:\FR\FM\29APN1.SGM 29APN1 Federal Register / Vol. 76, No. 83 / Friday, April 29, 2011 / Notices Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 21, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–10385 Filed 4–28–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ ATSDR) srobinson on DSKHWCL6B1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–4:45 p.m., May 18, 2011. 8:30 a.m.–3:15 p.m., May 19, 2011. Place: CDC, 4770 Buford Highway, Atlanta, Georgia 30341. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: The Secretary, Department of Health and Human Services (HHS) and by delegation, the Director, CDC and Administrator, NCEH/ATSDR, are authorized under Section 301 (42 U.S.C. 241) and Section 311 (42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1) Conduct, encourage, cooperate with, and assist other appropriate public authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention of physical and mental diseases and other impairments; (2) assist states and their political subdivisions in the prevention of infectious diseases and other preventable conditions and in the promotion of health and well being; and (3) train state and local personnel in health work. The BSC, NCEH/ATSDR provides advice and guidance to the Secretary, HHS; the Director, CDC and Administrator, ATSDR; and the Director, NCEH/ATSDR, regarding program goals, objectives, strategies, and priorities in fulfillment of the agency’s mission to protect and promote people’s health. The board provides advice and guidance that will assist NCEH/ATSDR in ensuring scientific quality, timeliness, utility, and dissemination of results. The board also provides guidance to help NCEH/ ATSDR work more efficiently and effectively with its various constituents and to fulfill its mission in protecting America’s health. VerDate Mar<15>2010 17:39 Apr 28, 2011 Jkt 223001 Matters To Be Discussed: The agenda items for the BSC Meeting on May 18–19, 2011 will include NCEH/ATSDR Office of the Director updates; Program Response to BSC Program Peer Review of the Division of Environmental Hazards and Health Effects; presentation on NCEH/ATSDR Internal Clearance and External Peer Review Policies and Procedures on Scientific Documents; presentation on Public Health Priority Level [GAO Table 2]; an update on The National Conversation; an overview of CDC’s public health activities related to imported drywall; a review of literature for Toxicological Profiles; a presentation on experimental approaches to risk assessment, and an update on CDC’s Response to earthquake, tsunami and radiation release in Japan. Agenda items are subject to change as priorities dictate. Supplementary Information: The public comment period is scheduled on Wednesday, May 18, 2011 from 4:15 p.m. until 4:30 p.m., and Thursday, May 19, 2011 from 2:15 p.m. until 2:30 p.m. Contact Person for More Information: Sandra Malcom, Committee Management Specialist, NCEH/ATSDR, 4770 Buford Highway, Mail Stop F–61, Chamblee, Georgia 30345; telephone 770/488–0575, Fax: 770/ 488–3377; E-mail: smalcom@cdc.gov. The deadline for notification of attendance is May 9, 2011. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 21, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2011–10393 Filed 4–28–11; 8:45 am] BILLING CODE 4163–18–P 24031 Obstetrician-Gynecologist Setting, FOA IP11–009, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., June 13, 2011 (Closed). Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770) 997–1100. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Strategies to Improve Vaccination Coverage of Children in Child Care Centers (CCCs) and Preschools, FOA IP11–006; Strategies to Increase Health Care providers Use of Population-Based Immunization Information Systems, FOA IP11–008; Effectiveness in an Intervention to Promote a Targeted Vaccination Program in the Obstetrician-Gynecologist Setting; FOA IP11–009, initial review.’’ Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E00, Atlanta, Georgia 30333, Telephone: (404) 498–2293. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: April 21, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–10390 Filed 4–28–11; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Centers for Disease Control and Prevention The meeting announced below concerns Strategies to Improve Vaccination Coverage of Children in Child Care Centers (CCCs) and Preschools, Funding Opportunity Announcement (FOA) IP11–006; Strategies to Increase Health Care Providers Use of Population-Based Immunization Information Systems, FOA IP11–008; and Effectiveness in an Intervention to Promote a Targeted Vaccination program in the PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Time and Date: 8 a.m.–4:30 p.m., May 18, 2011. Place: CDC, Global Communications Center, 1600 Clifton Road, NE., Building 19, Auditorium B, Atlanta, Georgia 30333. E:\FR\FM\29APN1.SGM 29APN1

Agencies

[Federal Register Volume 76, Number 83 (Friday, April 29, 2011)]
[Notices]
[Pages 24030-24031]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-10385]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Funding Opportunity Announcement GH11-002, 
Initial Review

    Correction: This notice was published in the Federal Register on 
April 12, 2011, Volume 76, Number 70, Page 20355. The contact person 
for the aforementioned meeting has been changed to the following:
    Contact Person for More Information: Diana Bartlett, M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop D-72, 
Atlanta, Georgia 30333, Telephone: (404) 639-4938.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the

[[Page 24031]]

Centers for Disease Control and Prevention and the Agency for Toxic 
Substances and Disease Registry.

    Dated: April 21, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-10385 Filed 4-28-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.